For the Inventor, By the Inventor

Enter inventor name

Carmel, IN, United States of America

Paul Leslie Ornstein

USPTO Granted Patents = 54

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 300(Granted Patents)

Forward Citations (Not Self Cited) = 249(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Indianapolis, IN (US) (1990 - 1997)
Carmel, CA (US) (2001)
Carmel, IN (US) (1995 - 2015)
Northbrook, IL (US) (2016)

Company Filing History:

54 out of 4,447

Eli Lilly and Company

Years Active: 1990-2016

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

mGluR Antagonists

Glutamate Receptors

Melanocortin Receptor Agonists

Analgesics

iGluR5 Antagonists

Sulfonamide Derivatives

Neuropeptide Y Receptor Antagonists

NMDA Receptor Antagonists

Decahydroisoquinoline Compounds

Pharmacological Agents

Excitatory Amino Acid Receptors

Isoquinoline Compounds

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9469632 - [object Object] (2016-10-18),

2. 9056844 - 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists (2015-06-16),

3. 7625932 - Pyrrole and pyrazole derivatives as potentiators of glutamate receptors (2009-12-01),

4. 7601738 - Excitatory amino acid receptor antagonists (2009-10-13),

5. 7314879 - Melanocortin receptor agonists (2008-01-01),

6. 7291619 - Melanocortin receptor agonists (2007-11-06),

7. 7247644 - Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics (2007-07-24),

8. 7205313 - Excitatory amino acid receptor antagonists (2007-04-17),

9. 7169777 - Melanocortin receptor agonists (2007-01-30),

10. 7157582 - [object Object] (2007-01-02),

11. 7135487 - Sulphonamide derivatives (2006-11-14),

12. 6953805 - Excitatory amino acid receptor antagonists (2005-10-11),

13. 6855823 - Selective iGluR5 receptor antagonists (2005-02-15),

14. 6855725 - Excitatory amino acid receptor antagonists (2005-02-15),

15. 6759418 - Selective iGluR5 receptor antagonists for the treatment of neurological disorders (2004-07-06),

Title: The Innovative Journey of Paul Leslie Ornstein

Introduction: Paul Leslie Ornstein, a talented inventor based in Carmel, IN (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Paul Leslie Ornstein holds several patents in various technological areas, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, Paul Leslie Ornstein has been recognized for his pioneering work in developing cutting-edge technologies that have revolutionized the industry. His dedication to innovation and problem-solving has led to the creation of groundbreaking solutions that have had a lasting impact.

Collaborations: Paul Leslie Ornstein has collaborated with leading experts and organizations in the technology sector, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have resulted in the development of groundbreaking inventions that have pushed the boundaries of what is possible.

Conclusion: Paul Leslie Ornstein's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit and commitment to pushing the boundaries of what is possible continue to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…